Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

New Range of Recombinant Fab Monoclonal Antibodies Launched at AACC 2013

publication date: Jul 24, 2013
 | 
author/source: In Press Public Relations Ltd

BBI Solutions, a world leader in immunoassay development and contract manufacturing, will launch its unique range of Recombinant Fab Monoclonal Antibodies on booth #3363 at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas.

BBI SolutionsThese matched antibodies pairs, developed using proprietary phage display selection and the Luminex platform, exhibit sub-nanomolar affinities, exceptional sensitivity, and provide assay developers with clinically relevant performance characteristics to 34 biomarkers, with more in development.

The new Recombinant Fab Mouse Monoclonal Antibodies from BBI Solutions exhibit significant advantages over standard mouse monoclonal antibodies.  From the screening process to testing in patient samples to ensure clinical significance, BBI Solutions’ methodology ensures that companies developing new assays have the most sensitive and reliable antibodies available in the market.

Because these new antibodies are grown in and purified from E. coli cultures, production is much quicker and more reliable than standard cell culture techniques, and large scale production is not an issue.

In regard to the new range, Dr. James Steggles, Commercial Manager at BBI Solutions, says, “Here at BBI Solutions it is our aim to ensure that we supply the market with antibodies that have world-class performance and give our customers significant advantages over their competitors.  Each antibody pair is the best from a billion clones screened and 4500 matched pairs tested.  By using this new range of monoclonal antibodies, they can produce clinical assays that are more sensitive and reliable than their competitors, as well as more cost-effective due to reduced R&D costs.”

BBI Solutions scientists will be at the AACC Conference to discuss the development of new products and any specific requirements customers may have. 


more about Recombinant Fab Monoclonal Antibodies


more about BBI Solutions


 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events